期刊文献+

白藜芦醇脂质体的制备及体外消化研究 被引量:6

Preparation and Digestion in Vitro of Resveratrol Liposomes
下载PDF
导出
摘要 采用薄膜超声法制备白藜芦醇脂质体,选择分子量为2000的聚乙二醇(PEG-2000)对其修饰,单因素试验确定了大豆卵磷脂、胆固醇及白藜芦醇的最优质量比,利用红外光谱表征其分子结构。建立胃肠道连续消化体系,研究白藜芦醇脂质体的体外消化。红外光谱证实脂质体构建成功。确定大豆卵磷脂∶胆固醇(质量比)=6∶1,大豆卵磷脂∶白藜芦醇(质量比)=20∶1,1 mg/mL PEG-2000的磷酸盐缓冲液制备的PEG-2000修饰白藜芦醇脂质体包封率最优,为73.98%;消化体系中消化率达26.44%,具有一定的缓释作用;PEG-2000修饰后的白藜芦醇脂质体稳定性更高。 The resveratrol liposomes(PEG-RES-L)were prepared by thin-film ultrasound method and modified with PEG-2000.The optimal mass ratios of soy lecithin,cholesterol,and resveratrol was confirmed with a single factor experiment.The prepared liposome was characterized by infrared spectroscopy.A gastrointestinal tract digestion system was established to study the in vitro digestion of resveratrol liposomes.The results showed that resveratrol was successfully entrapped and confirmed by infrared spectroscopy.The optimum conditions were 6∶1 of the weight ratio of soybean lecithin and cholesterol,20∶1 of soy lecithin and RES,and 1mg/mL of PEG-2000 phosphate buffer.The optimal encapsulation efficiency was 73.98%.The in vitro digestion studies of resveratrol liposomes showed that the cumulative digestibility of the modified liposomes in the simulated digestive tract continuous digestive system in vitro was 26.44% with a slower release.The liposome had a higher stability after the modification of PEG-2000.
作者 范超中 庄满意 温浩 李晨晨 普一涵 吕亚莉 李静 FAN Chaozhong;ZHUANG Manyi;WEN Hao;LI Chenchen;PU Yihan;LV Yali;LI Jing(College of Food Science and Engineering,Tianjin University of Science and Technology,Tianjin 300457,China)
出处 《农产品加工》 2020年第24期1-4,8,共5页 Farm Products Processing
基金 天津科技大学大学生实验室创新基金项目(1814A206) 天津市高等学校科技发展基金计划项目(20120608)。
关键词 白藜芦醇 脂质体 优化 PEG 体外消化 resveratrol liposome optimization PEG digestion in vitro
  • 相关文献

参考文献2

二级参考文献68

  • 1王新春,侯世祥,李文,李小英,周亚伟.白藜芦醇纳米脂质体体外释药和大鼠小肠吸收特性的研究[J].中国中药杂志,2007,32(11):1084-1088. 被引量:26
  • 2BANGHAM A D, STANDISH M M, WATKINS J C. Diffusion of univalent inos across the lameUa of swollen phospholipids[J]. Journal of Molecular Biology, 1965, 13(1): 238-252.
  • 3LASIC D D, PAPAHADJOPOULOS D. Liposomes revisited[J]. Science, 1995, 267: 1275-1276.
  • 4GOYAL P, GOUAL K, VIJAYA KUMAR S G, et al. Liposomal drug delivery systems-clinical applications[J]. Acta Pharmaceutica, 2005, 55(1): 1-25.
  • 5JESORKA A, ORWAR O. Liposomes: technologies and analytical applicalions[J]. Annual Review of Analytical Chemistry, 2008, 1: 801-832.
  • 6PUPO E, PADRON A, SANTANA E, et al. Preparation of plasmid DNA-containing liposomes using a high-pressure homogenization- extrusion technique[J]. Journal of Controlled Release, 2005, 104(2): 379-396.
  • 7ZHENG Xiaoli, LU Jianping, DENG Li, et al. Preparation and characterization of magnetic cationic liposome in gene delivery[J]. International Journal of Pharmaceutics, 2009, 366(1 ): 211-217.
  • 8YANG Li, YANG Wenzhan, BI Dianzhou, et al. A novel method to prepare highly encapsulated interferon-a-2b containing liposomes for intramuscular sustained release[J]. European Journal of Pharmaceutics and Biopharmaceutics, 2006, 64(1): 9-15.
  • 9LIU Nan, PARK Hyunjin. Chitosan-coated nanoliposome as vitamin E carrier[J]. Journal of Microencapsulafion, 2009, 26(3): 235-242.
  • 10LIU Weilin, LIU Wei, LIU Chengmei, et al. Preparation and evaluation of easy energy supply property of medium-chain fatty acids liposomes[J]. Journal of Microencapsulation, 2011, 28(8): 783-790.

共引文献25

同被引文献57

引证文献6

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部